{"id":"NCT01214811","sponsor":"Molnlycke Health Care AB","briefTitle":"Open Multi-centre Investigation to Evaluate Signs and Symptoms of Local Inflammation/Infection on Chronic Ulcers and Partial Thickness Burns When Using Mepilex Border Ag as an Anti-microbial Wound Dressing","officialTitle":"Open Multi-centre Investigation to Evaluate Signs and Symptoms of Local Inflammation/Infection on Chronic Ulcers and Partial Thickness Burns When Using Mepilex Border Ag as an Anti-microbial Wound Dressing","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-09","primaryCompletion":"2011-09","completion":"2011-12","firstPosted":"2010-10-05","resultsPosted":"2013-02-26","lastUpdate":"2013-03-08"},"enrollment":27,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Inflammation","Burns","Ulcers"],"interventions":[{"type":"DEVICE","name":"Mepilex Border Ag","otherNames":[]}],"arms":[{"label":"Mepilex Border Ag","type":"OTHER"}],"summary":"The purpose of this study is to evaluate the change in signs of inflammation/local infection when Mepilex Border Ag is used in normal clinical practice when used on chronic ulcers (venous leg, diabetic foot and pressure ulcers) and partial thickness burns in need\\* of topical antimicrobial treatment according to the physician.","primaryOutcome":{"measure":"Wound Are at Baseline","timeFrame":"Baseline","effectByArm":[],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":12},"locations":{"siteCount":3,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":27},"commonTop":[]}}